Home > Healthcare > Medical Devices > Therapeutic Devices > drug eluting balloon catheters market
Get a free sample of Drug-eluting Balloon Catheters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Drug-eluting Balloon Catheters Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market is competitive, with a mix of large multinationals like B. Braun, Becton, Dickinson and Company, and Boston Scientific Corporation leading in innovation and extensive product portfolios. Regional companies and new entrants, particularly from Asia Pacific, are also making significant strides. The market is characterized by frequent technological advancements, such as improved vaccine efficacy, enhanced safety profiles, and better storage and distribution methods, which drive ongoing product development. Strategic partnerships, mergers, and acquisitions are common as companies seek to expand market reach and enhance their technological capabilities.
Prominent players operating in the drug-eluting balloon catheters industry include:
The global drug-eluting balloon catheters industry was valued at USD 637.8 million in 2024 and is expected to grow at a 9.9% CAGR from 2025 to 2034, driven by the increasing prevalence of peripheral and cardiovascular diseases.
The peripheral vascular disease drug-eluting balloon catheters segment generated USD 353 million in revenue in 2024, owing to their effectiveness in treating complex lesions.
Key players in the market include Aachen Resonance GmbH, B. Braun, Becton, Dickinson and Company, Biosensors International, Biotronik AG, Boston Scientific Corporation, Eurocor GmbH, iVascular S.L.U., Lepu Medical Technology (Beijing) Co. Ltd., MedAlliance, and Medtronic plc.
The North America drug-eluting balloon catheters market recorded USD 272.2 million in revenue in 2024 and is anticipated to grow at a CAGR of 8.4% from 2025 to 2034, supported by advanced healthcare infrastructure and a high prevalence of cardiovascular diseases.